- socially bharat
- September 20, 2024
Takeda to Present Additional Clinical Trial Study Data Highlighting the Impact of Orexin Agonist TAK-861 on the Burden of Narcolepsy at Sleep Europe 2024
Osaka, Japan & Cambridge, Mass., United States: − Presentations Include New Data from the TAK-861-2001 Phase 2b Trial in